ELEV
Closed
Elevation Oncology Inc
0.3685
+0.0014 (+0.38%)
Last Update: 01 Jul 2025 23:09:00
Yesterday: 0.3671
Day's Range: 0.3651 - 0.37
Send
sign up or login to leave a comment!
When Written:
1.9
Elevation Oncology Inc is a clinical stage biopharmaceutical company that focuses on developing precision medicines for the treatment of cancer. The company's mission is to improve the lives of cancer patients by identifying and targeting specific genomic alterations that drive their disease. Elevation Oncology's lead drug candidate, seribantumab, is a monoclonal antibody that targets the HER3 receptor, which is overexpressed in many types of cancer. The company is also developing a pipeline of other precision medicines that target specific genomic alterations in cancer cells. Elevation Oncology was founded in 2018 and is headquartered in New York, NY.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








